BNP PARIBAS ASSET MANAGEMENT Holding S.A.
Position in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 1520354
Paris, I0
Position in CRNX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$62,809,093
+$467,812 QoQ
Shares Held
1,678,490
-2.2% QoQ
Ownership
1.58%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#18
of 266 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $2,249,207,592 across 136 Biotechnology names. CRNX ranks #10 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
897,893 | $446,010,389 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
331,560 | $206,740,921 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
799,297 | $192,606,596 | |
| 4 | ARGX |
Argenx SE
|
121,786 | $112,989,396 | |
| 5 | INCY |
Incyte Corp
|
937,763 | $106,304,813 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
1,290,731 | $77,908,522 | |
| 7 | VCEL |
Vericel Corp
|
1,639,988 | $72,963,065 | |
| 8 | CYTK |
Cytokinetics Inc
|
827,810 | $70,521,132 |
All Filings in CRNX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $62,809,093 | 1,678,490 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $62,341,281 | 1,716,445 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $61,789,631 | 1,327,382 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $34,737,391 | 834,031 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $20,497,797 | 712,719 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $20,487,540 | 610,839 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $29,454,356 | 576,068 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $25,109,569 | 491,381 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $24,465,820 | 546,234 | Shares | Defined | 2024-07-30 | |
| 2024-03-31 | $25,404,161 | 542,708 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $23,421,922 | 658,289 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $18,836,245 | 633,364 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $11,557,036 | 641,345 | Shares | Defined | 2023-08-08 | |
| 2023-03-31 | $11,100,688 | 691,201 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $11,175,627 | 610,690 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $8,944,429 | 455,419 | Shares | Defined | 2022-11-10 | |
| No filing history on record for this holder in this stock. | ||||||